Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotoxin therapy for CNS tumor.

Edward Rustamzadeh1, Walter C Low, Daniel A Vallera

  • 1Department of Neurosurgery, Graduate School, University of Minnesota, Minneapolis, MN, USA. erusta@hotmail.com

Journal of Neuro-Oncology
|September 4, 2003
PubMed
Summary

Immunotoxins show promise as an adjuvant therapy for malignant brain tumors, but further research is needed. This review details their history, design, and clinical trial outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potential role of transcranial direct current stimulation in experimental ischemic stroke in adult male albino rats.

Scientific reports·2026
Same author

Differential gene expression analysis in French bulldog high grade oligodendroglioma: breed-associated differences in tumor and tumor microenvironment gene expression.

Companion animal health and genetics·2026
Same author

Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review.

Toxins·2026
Same author

The use of therapeutic exosomes for <i>in vivo</i> wound healing.

Cell transplantation·2026
Same author

Astrocyte to neuron reprogramming with NeuroD1 for repair in canine stroke.

Frontiers in stroke·2026
Same author

Ischemia Reperfusion Injury Induced Systemic Inflammatory Response Following Interspecies Liver Transplantation.

Hepatic medicine : evidence and research·2025

Area of Science:

  • Oncology
  • Immunotherapy
  • Neurosurgery

Background:

  • Malignant brain tumors have a poor prognosis despite standard treatments like surgery, chemotherapy, and radiation.
  • Immunotoxins represent a novel adjuvant therapy approach for brain tumors.
  • Recent clinical research has increased, with numerous trials investigating immunotoxin efficacy.

Purpose of the Study:

  • To provide a comprehensive review of immunotoxins in the context of malignant brain tumor treatment.
  • To discuss the historical development and design principles of immunotoxins.
  • To analyze the toxicity and pharmacokinetic profiles of immunotoxins.

Main Methods:

  • Literature review of clinically-oriented research on immunotoxins.
  • Analysis of published clinical trials involving immunotoxins.
  • Detailed discussion of immunotoxin history, design, toxicity, and pharmacokinetics.

Main Results:

  • Immunotoxins have emerged as a significant area of research for brain tumors.
  • Clinical trials show encouraging but not definitive results, falling short of the initial 'magic bullet' concept.
  • Extensive data on immunotoxin history, design, toxicity, and pharmacokinetics are available.

Conclusions:

  • Immunotoxins are a developing adjuvant therapy for malignant brain tumors.
  • While promising, immunotoxins require further investigation to optimize their clinical application.
  • A thorough understanding of their characteristics is crucial for future development.

Related Experiment Videos